Clinical Outcomes of Newly Diagnosed Multiple Myeloma Patients with Elevated Lactate Dehydrogenase Who Underwent Autologous Hematopoietic Stem Cell Transplantation

被引:0
|
作者
Bal, Susan [1 ]
Choi, Kwangmin [2 ]
Landau, Heather J. [3 ]
Starczynowski, Daniel T. [2 ,4 ]
Girnius, Saulius K. [5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, Scarsdale, NY USA
[4] Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH USA
[5] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
关键词
D O I
10.1182/blood-2018-99-120077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4623
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Clinical Outcomes of Newly Diagnosed Multiple Myeloma Patients with Elevated Lactate Dehydrogenase Who Underwent Autologous Hematopoietic Stem Cell Transplantation
    Bal, Susan
    Choi, Kwangmin
    Cincinnati, O. H.
    Landau, Heather
    Starczynowski, Daniel
    Girnius, Saulius
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [2] The importance of autologous stem cell transplantation in improving outcomes in newly diagnosed patients with multiple myeloma
    Gertz, Morie A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024,
  • [3] Daratumumab Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
    Ma, Panelyi
    Xiao, Xiubin
    Yuan, Shunzong
    Chen, Xilin
    Zhao, Shihua
    Cheng, Nana
    Lu, Yun
    Chen, Junli
    Wang, Yueqi
    Huang, Wenrong
    BLOOD, 2023, 142
  • [4] Utilization of Autologous Stem Cell Transplantation in Older Patients with Newly Diagnosed Multiple Myeloma
    King, Justin
    Fiala, Mark A.
    Goldsmith, Scott R.
    Stockerl-Goldstein, Keith E.
    Schroeder, Mark A.
    Ghobadi, Armin
    Vij, Ravi
    Wildes, Tanya M.
    BLOOD, 2019, 134
  • [5] Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma
    James A. Davis
    Aswani Thurlapati
    Erin Weeda
    Kelly J. Gaffney
    Deidra Smith
    Andy Maldonado
    Katelynn Granger
    Kristy E. Martin
    Yolanda M. Williams
    Taylor Herrington
    Arash Velayati
    Jonathan K. Bakos
    Kimberly Green
    Hamza Hashmi
    Annals of Hematology, 2024, 103 : 251 - 258
  • [6] Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma
    Davis, James A.
    Thurlapati, Aswani
    Weeda, Erin
    Gaffney, Kelly J.
    Smith, Deidra
    Maldonado, Andy
    Granger, Katelynn
    Martin, Kristy E.
    Williams, Yolanda M.
    Herrington, Taylor
    Velayati, Arash
    Bakos, Jonathan K.
    Green, Kimberly
    Hashmi, Hamza
    ANNALS OF HEMATOLOGY, 2024, 103 (01) : 251 - 258
  • [7] The type of upfront induction therapy for newly diagnosed multiple myeloma patients has no significant impact on clinical outcomes after autologous hematopoietic stem cell transplantation
    Chung, Stephen S.
    Spitzer, Thomas R.
    Ting, David T.
    Dube, Christine
    Yee, Andrew J.
    Ballen, Karen
    McAfee, Steven L.
    Attar, Eyal
    Dey, Bimalangshu R.
    BLOOD, 2007, 110 (11) : 364B - 364B
  • [8] Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation
    Fan, Liping
    Fu, Danhui
    Zhang, Jinping
    Huang, Haobo
    Wang, Qingqing
    Ye, Yamei
    Xie, Qianling
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [9] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
    Patir, P.
    Soyer, N.
    Tombuloglu, M.
    Tobu, M.
    Sahin, F.
    Donmez, A.
    Saydam, G.
    Vural, F.
    LEUKEMIA RESEARCH, 2016, 49 : S27 - S28
  • [10] Treatment Pattern and Overall Survival in Newly Diagnosed Multiple Myeloma Patients who are not Eligible for Autologous Stem Cell Transplantation
    He, Jianming
    Qiu, Lugui
    Schmerold, Luke
    Potluri, Ravi
    Li, Lin
    Hu, Peter
    Nemat, Sepideh
    Smugar, Steven S.
    Appiani, Carlos
    Mehra, Maneesha
    Richarz, Ute
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E229 - E229